Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antibody-mediated rejection after liver transplantation-relevance of C1q and C3d-binding antibodies

B. Kovandova, A. Slavcev, Z. Sekerkova, E. Honsova, P. Trunecka,

. 2018 ; 92 Suppl 2 (-) : 34-37. [pub] -

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035108

Grantová podpora
NV16-27477A MZ0 CEP - Centrální evidence projektů

The aim of our study was to evaluate the relevance of complement-binding donor-specific antibodies (DSA) for prediction of antibody-mediated rejection (AMR) after liver transplantation. Sera from 123 liver transplant recipients were retrospectively defined for HLA specificity and complement-fixing activity using the single antigen beads, C1q and C3d techniques. Liver-recipients' sera were tested before transplantation, 3, 6 months and 1 year after transplantation. Patients were followed up for graft survival and rejection incidence for 1 year after transplantation. All patients with pretransplant complement-binding DSA developed severe AMR after transplantation, while three recipients out of four, who produced de novo complement-fixing DSA, developed AMR. Definition of DSA with respect to complement-fixing activity may provide clinically relevant information about the risk of AMR after liver transplantation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035108
003      
CZ-PrNML
005      
20191014101237.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/tan.13354 $2 doi
035    __
$a (PubMed)30054978
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kovandova, Barbora $u Department of Immunogenetics, IKEM, Prague, Czech Republic.
245    10
$a Antibody-mediated rejection after liver transplantation-relevance of C1q and C3d-binding antibodies / $c B. Kovandova, A. Slavcev, Z. Sekerkova, E. Honsova, P. Trunecka,
520    9_
$a The aim of our study was to evaluate the relevance of complement-binding donor-specific antibodies (DSA) for prediction of antibody-mediated rejection (AMR) after liver transplantation. Sera from 123 liver transplant recipients were retrospectively defined for HLA specificity and complement-fixing activity using the single antigen beads, C1q and C3d techniques. Liver-recipients' sera were tested before transplantation, 3, 6 months and 1 year after transplantation. Patients were followed up for graft survival and rejection incidence for 1 year after transplantation. All patients with pretransplant complement-binding DSA developed severe AMR after transplantation, while three recipients out of four, who produced de novo complement-fixing DSA, developed AMR. Definition of DSA with respect to complement-fixing activity may provide clinically relevant information about the risk of AMR after liver transplantation.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a dítě $7 D002648
650    _2
$a komplement C1q $x metabolismus $7 D015922
650    _2
$a komplement C3d $x metabolismus $7 D015933
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a rejekce štěpu $x krev $x diagnóza $x imunologie $x patologie $7 D006084
650    12
$a přežívání štěpu $7 D006085
650    _2
$a testování histokompatibility $x metody $7 D006650
650    _2
$a lidé $7 D006801
650    _2
$a isoprotilátky $x krev $7 D007518
650    12
$a transplantace jater $7 D016031
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a dárci tkání $7 D014019
650    _2
$a homologní transplantace $7 D014184
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Slavcev, Antonij $u Department of Immunogenetics, IKEM, Prague, Czech Republic.
700    1_
$a Sekerkova, Zuzana $u Department of Immunogenetics, IKEM, Prague, Czech Republic.
700    1_
$a Honsova, Eva $u Department of Clinical & Transplantation Pathology, IKEM, Prague, Czech Republic.
700    1_
$a Trunecka, Pavel $u Clinic of Hepatology, IKEM, Prague, Czech Republic.
773    0_
$w MED00195031 $t HLA $x 2059-2310 $g Roč. 92 Suppl 2, č. - (2018), s. 34-37
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30054978 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191014101701 $b ABA008
999    __
$a ok $b bmc $g 1451768 $s 1073658
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 92 Suppl 2 $c - $d 34-37 $e - $i 2059-2310 $m HLA $n HLA $x MED00195031
GRA    __
$a NV16-27477A $p MZ0
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Možnosti archivace